GALT icon

Galectin Therapeutics
GALT

Overview Fund Activity

26 hedge funds and large institutions have $10.4M invested in Galectin Therapeutics in 2013 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
26
Holders Change
+10
Holders Change %
+62.5%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
$204K
Net Calls
-$204K
Net Calls Change
-$204K

Top Buyers

1
EI
1
EAM Investors
California
$1.52M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.6M
3
BCA
3
Benchmark Capital Advisors
New York
$653K
4
Northern Trust
4
Northern Trust
Illinois
$320K
5
LTFS
5
Ladenburg Thalmann Financial Services
Florida
$198K

Top Sellers

1
TFCP
1
Twin Focus Capital Partners
Massachusetts
$1.07M
2
Neuberger Berman Group
2
Neuberger Berman Group
New York
$2.66M
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$1K
Name Market Value Shares Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$1K 100 -150 -60%
Bank of America
27
Bank of America
North Carolina
– – -44 Closed
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
– – -5 Closed
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
– – – –
1
2